IL2 and major depressive disorder: Major depressive disorders have been reported in patients being treated with the recombinant cytokines interleukin-2 (IL-2) and interferon-α (IFN-α) [43], and chronic inflammatory diseases such as coronary artery and autoimmune diseases have been associated with an increased incidence of mood disorders [37].